Meixia Zhang Selected Research

N- (N- ((1- tert- butyloxycarbonyl)indolin- 2- carbonyl)indolin- 2- carbonyl)- (N- epsilon- benzyloxycarbonyl)- 2- lysine methyl ester

5/2002

Anti-inflammatory effects of a cyclosporine receptor-binding compound, D-43787.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meixia Zhang Research Topics

Disease

13	Neoplasms (Cancer) 08/2022 - 05/2008
8	Macular Degeneration (Age-Related Maculopathy) 05/2022 - 06/2014
8	Ischemic Stroke 11/2018 - 01/2017
6	Inflammation (Inflammations) 01/2022 - 04/2006
6	Stroke (Strokes) 10/2020 - 01/2017
5	Hepatocellular Carcinoma (Hepatoma) 08/2022 - 03/2009
5	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2022 - 07/2019
4	Fibrosis (Cirrhosis) 01/2021 - 06/2019
4	Infarction (Infarctions) 01/2019 - 10/2017
4	Laryngeal Neoplasms (Laryngeal Cancer) 09/2010 - 05/2008
3	Retinal Diseases 05/2022 - 03/2014
3	Central Serous Chorioretinopathy 10/2021 - 01/2020
3	Retinal Vein Occlusion 05/2021 - 09/2020
3	Infections 11/2020 - 01/2016
3	Eosinophilia 04/2005 - 04/2002
2	Aneurysm (Aneurysms) 04/2022 - 05/2021
2	Edema (Dropsy) 01/2022 - 05/2002
2	Choroidal Neovascularization 01/2022 - 12/2014
2	Pneumonia (Pneumonitis) 08/2021 - 04/2005
2	Ischemia 01/2021 - 01/2014
2	Atrial Fibrillation 01/2021 - 01/2020
2	Macular Edema 01/2021 - 09/2020
2	Reperfusion Injury 10/2017 - 01/2014
2	Hemorrhage 10/2017 - 04/2013
2	Retinal Neovascularization 01/2012 - 01/2006
2	Squamous Cell Carcinoma of Head and Neck 09/2010 - 10/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2010 - 04/2010
2	Asthma (Bronchial Asthma) 04/2005 - 04/2002
1	Telangiectasis (Telangiectasia) 05/2022
1	Retinal Degeneration 05/2022
1	Bites and Stings (Sting) 03/2022
1	Pathologic Neovascularization 03/2022
1	Vascular Diseases (Vascular Disease) 03/2022
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2022
1	Diabetes Complications 12/2021
1	Hyperglycemia 12/2021
1	Necrosis 12/2021
1	Acute Lung Injury 08/2021
1	Retinal Hemorrhage 05/2021
1	Retinal Telangiectasis 05/2021
1	Pterygium 04/2021
1	Disease Progression 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Cataract (Cataracts) 01/2021
1	Eye Diseases (Eye Disease) 01/2021
1	Glaucoma 01/2021
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021
1	Uveitis 01/2021
1	Keratitis 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Craniosynostoses (Craniosynostosis) 11/2020
1	Bovine Mastitis 04/2020

Drug/Important Bio-Agent (IBA)

10	Retinaldehyde (Retinal)IBA 05/2022 - 01/2006
8	cucurbitacin BIBA 07/2017 - 05/2008
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 01/2006
4	CytokinesIBA 01/2022 - 04/2005
4	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2018 - 10/2017
3	Proteins (Proteins, Gene)FDA Link 08/2021 - 01/2013
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 03/2009
3	IgYIBA 11/2020 - 01/2016
3	Mitogen-Activated Protein KinasesIBA 06/2017 - 04/2005
2	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 12/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2020
2	Blood Glucose (Blood Sugar)IBA 12/2021 - 01/2021
2	Peptides (Polypeptides)IBA 01/2021 - 10/2010
2	Caveolin 1IBA 01/2021 - 10/2020
2	Biological ProductsIBA 01/2020 - 06/2017
2	CollagenIBA 01/2020 - 04/2006
2	KH902 fusion proteinIBA 07/2019 - 01/2019
2	Fingolimod Hydrochloride (FTY720)FDA Link 11/2018 - 10/2017
2	Therapeutic UsesIBA 07/2017 - 04/2012
2	TriterpenesIBA 08/2010 - 04/2010
2	U 0126 (UO 126)IBA 04/2005 - 04/2002
1	Proprotein Convertase 9IBA 08/2022
1	IronIBA 01/2022
1	AntioxidantsIBA 01/2022
1	artenimol (dihydroartemisinin)IBA 01/2022
1	purineIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	necrostatin-1IBA 12/2021
1	LipopolysaccharidesIBA 08/2021
1	ChemokinesIBA 08/2021
1	cirsilineolIBA 08/2021
1	Peroxidase (Myeloperoxidase)IBA 08/2021
1	Mineralocorticoid Receptor AntagonistsIBA 04/2021
1	Proteasome InhibitorsIBA 04/2021
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 04/2021
1	InflammasomesIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 11/2020
1	danaparoid (Orgaran)FDA Link 10/2020
1	SteroidsIBA 09/2020
1	Vascular Endothelial Growth FactorsIBA 09/2020

Therapy/Procedure

22	Therapeutics 05/2022 - 04/2002
4	Drug Therapy (Chemotherapy) 01/2021 - 06/2008
3	Thrombectomy 01/2019 - 01/2017
2	Lasers (Laser) 01/2022 - 04/2013
2	Aftercare (After-Treatment) 01/2021 - 03/2014
2	Transplantation 07/2014 - 03/2014
1	Vitrectomy 12/2021
1	Oral Administration 11/2020